Strategic Advocates’s Cerence CRNC Stock Holding History

Strategic Advocates’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$22	–	333
2025 Q4	$22	Hold	2	–	–	﹤0.01%	622
2025 Q3	$25	Buy	+2	New	+$20	﹤0.01%	600

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OFCM

One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Strategic Advocates's CRNC Position: Q1 2026 in Review

Strategic Advocates sold out of Cerence (CRNC) in Q1 2026, closing a stake of 2 shares — an estimated $22 sold.

Strategic Advocates first reported a position in CRNC in Q3 2025 and held it in 2 quarters. The position peaked at $25 in Q3 2025. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

Strategic Advocates reported no remaining Cerence position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 2 Cerence shares in Q1 2026, an estimated $22.
Strategic Advocates first reported a position in Cerence in Q3 2025 and held it in 2 quarters.
Strategic Advocates's Cerence position peaked at $25 in Q3 2025.
195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.